PARGY-LAD
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (8β)- N,N- diethyl- 6-prop- 2-yn- 1-yl- 9,10- didehydroergoline- 8- carboxamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| ATC code | ? |
| ChemSpider | 21106360  |
| Synonyms | PARGY-LAD, 6-propynyl- 6-nor- Lysergic acid diethylamide, (6aR,9R)- N,N- diethyl- 7-propynyl- 4,6,6a,7,8,9- hexahydroindolo- [4,3-fg] quinoline- 9- carboxamide |
| Chemical data | |
| Formula | C22H25N3O |
| Mol. mass | 347.46 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
PARGY-LAD is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PARGY-LAD is a hallucinogenic drug similar to LSD, but is slightly less potent than LSD with a dose of 160 micrograms producing only mild effects, and 500 micrograms required for full activity.
 |
This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
